{
    "clinical_study": {
        "@rank": "126083", 
        "arm_group": [
            {
                "arm_group_label": "Infiltration, analgesic effect", 
                "arm_group_type": "Active Comparator", 
                "description": "10ml 0.5% bupivacaine each side Block Injection of local anesthetic at pudendal nerve"
            }, 
            {
                "arm_group_label": "Spinal block", 
                "arm_group_type": "Active Comparator", 
                "description": "10 mg of hyperbaric 0.5% bupivacaine Injection of anesthetic at subarachnoidal space"
            }
        ], 
        "brief_summary": {
            "textblock": "There will be compared the postoperative analgesic effect of infiltration or spinal block\n      for hemorrhoidectomy"
        }, 
        "brief_title": "Subarachnoid or Infiltration for Hemorrhoidectomy", 
        "completion_date": {
            "#text": "March 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Hemorrhoid", 
        "condition_browse": {
            "mesh_term": "Hemorrhoids"
        }, 
        "detailed_description": {
            "textblock": "This is a prospective, randomized study, including 40 patients between 18 and 60 years, of\n      both genders, ASA 1 or 2.\n\n      Patients in group 1 (n = 20) will be submitted to spinal block and group 2 (n = 20) to\n      infiltration. The spinal block will be performed with 10 mg of 0.5% bupivacaine. The\n      infiltration will be performed with 10 ml of 0.5% bupivacaine with epinephrine on each side.\n\n      Will be evaluated: intensity of pain on a numerical scale from 0 to 10 every 15 minutes,\n      relaxation of the sphincter muscles, intensity of pain after the operation every 30 minutes\n      until reached the criteria for discharge, muscle strength of the lower limbs every 30\n      minutes, BP, HR, SO2, FR, other items that determine the conditions of discharge (urine\n      output, nausea and vomiting), time to hospital discharge, and duration of analgesia. Adverse\n      effects and complications will be noted."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Will be included 50 patients, ASA physical status 1 or 2 undergoing hemorrhoidectomy\n             after approval by the Ethics Committee and signed Consent Form\n\n        Exclusion Criteria:\n\n          -  There will be excluded patients with associated diseases (fistula, fissure),\n             infection at the puncture site, using anticoagulants or analgesics (up to 2 weeks\n             before the procedure) and pregnant."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "60 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "40", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 23, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01927874", 
            "org_study_id": "Bl.Pud"
        }, 
        "intervention": [
            {
                "arm_group_label": "Infiltration, analgesic effect", 
                "description": "injection of local anesthetic", 
                "intervention_name": "Infiltration", 
                "intervention_type": "Procedure", 
                "other_name": "Local Infiltration"
            }, 
            {
                "arm_group_label": "Spinal block", 
                "description": "injection of anesthetic", 
                "intervention_name": "Spinal block", 
                "intervention_type": "Procedure", 
                "other_name": "subarachnoidal block"
            }, 
            {
                "arm_group_label": "Infiltration, analgesic effect", 
                "description": "10ml 0.5% bupivacaine. Injection of local anesthetic around the nerve", 
                "intervention_name": "Bupivacaine", 
                "intervention_type": "Drug", 
                "other_name": "Local infiltration"
            }, 
            {
                "arm_group_label": "Spinal block", 
                "intervention_name": "10 mg of hyperbaric 0.5% bupivacaine", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Analgesics", 
                "Anesthetics, Local", 
                "Bupivacaine", 
                "Anesthetics"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Pudendal block", 
            "hemorrhoidectomy", 
            "Postoperative pain"
        ], 
        "lastchanged_date": "February 24, 2014", 
        "location": {
            "contact": {
                "last_name": "Rioko K Sakata, PhD"
            }, 
            "contact_backup": {
                "last_name": "Adriana M Issy, PhD"
            }, 
            "facility": {
                "address": {
                    "city": "S\u00e3o Paulo", 
                    "country": "Brazil", 
                    "zip": "04044020"
                }, 
                "name": "Universidade Federal de S\u00e3o Paulo"
            }, 
            "investigator": {
                "last_name": "Rioko K Sakata, PhD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Brazil"
        }, 
        "number_of_arms": "2", 
        "official_title": "Comparative Study of the Analgesic Effect of Subarachnoid or Infiltration for Hemorrhoidectomy", 
        "other_outcome": {
            "measure": "Duration of motor blockade", 
            "safety_issue": "Yes", 
            "time_frame": "24 hours"
        }, 
        "overall_contact": {
            "email": "riokoks.dcir@epm.br", 
            "last_name": "Rioko K Sakata, PhD", 
            "phone": "055 11 50847463"
        }, 
        "overall_official": {
            "affiliation": "Universidade Federal de S\u00e3o Paulo", 
            "last_name": "Rioko K Sakata, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Brazil: Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "September 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Numerical score", 
            "measure": "Pain intensity", 
            "safety_issue": "No", 
            "time_frame": "24 hours"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01927874"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Federal University of S\u00e3o Paulo", 
            "investigator_full_name": "Rioko Kimiko Sakata", 
            "investigator_title": "PhD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "Time to discharge", 
            "safety_issue": "Yes", 
            "time_frame": "24 hours"
        }, 
        "source": "Federal University of S\u00e3o Paulo", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Federal University of S\u00e3o Paulo", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}